Novo Nordisk has announced an exclusive partnership with Emcure Pharmaceuticals to distribute and market its new weight-loss drug brand, Poviztra, in India. The Danish pharmaceutical giant will introduce Poviztra as a 2.4 mg semaglutide injection, representing a separate brand of its globally successful treatment, Wegovy. This strategic collaboration aims to enhance Continue Reading
